Sponsor Pipeline

Restem, LLC. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Phase 3
Active Trials by Phase
Phase 2/3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07160205 Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With… Idiopathic Inflammatory Myositis (IIM) Recruiting
Phase 1
NCT07086521 Safety and Preliminary Efficacy of ULSC in Facioscapulohumeral Muscular Dystrophy (FSHD) FSHD - Facioscapulohumeral Muscular Dystrophy Recruiting
Get alerts when Restem, LLC.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free